脓毒症研究热点总结2026

脓毒症研究热点总结2026研究概览脓毒症仍是全球重症医学领域的核心挑战，年死亡人数超过1100万。近两年研究呈现从传统抗炎治疗向精准免疫调控、代谢干预和多组学驱动的个体化治疗转变的显著趋势。以下基于MeSH术语频率和文献聚类，识别出6大研究热点。热点一：脓毒症免疫代谢重编程(ImmunometabolicReprogramming)热度指标:metabolism(156次),immunology(117次),metabolicreprogramming,mitochondria,glycolysis,oxidativestress热点分析:免疫代谢是2024-2026年脓毒症领域最活跃的方向。研究已从单纯的炎症因子调控，深入到巨噬细胞/中性粒细胞的代谢重编程机制——包括糖酵解转换、线粒体功能障碍、脂肪酸氧化异常等。乳酸化修饰(Lactylation)作为连接代谢与免疫的表观遗传桥梁正成为新前沿。铜死亡(Cuproptosis)等新型细胞死亡方式也开始进入脓毒症研究视野。代表文献:PMID期刊标题41983123FrontImmunol(2026)Immunometabolicreprogramminginsepsis:mechanisms,clinicalendotypes,andtherapeuticimplications41930580IntJMolMed(2026)Macrophagemetabolismreprogramminginsepsis:Pathogenesisandtherapeuticimplications41869341FrontImmunol(2026)Lactylationmodification-abridgebetweensepsisandmacrophagemetabolicreprogramming42077589DrugDesDevelTher(2026)CuproptosisinSepsis:CellType-SpecificMechanismsandClinicalProspects41842952JClinInvest(2026)Estrogenreceptorbetadeficiencyincreasessusceptibilitytosepsisthroughmetabolicdysregulation热点二：生物标志物与AI驱动的早期诊断热度指标:biomarkers(19次),diagnosis(25次),machinelearning(4次),precisionmedicine,prognosis(11次)热点分析:脓毒症早期识别仍是临床瓶颈。近两年研究重点从单一标志物(如降钙素原)转向多标志物组合+机器学习模型。可解释性AI(XAI)在脓毒症预测中的应用成为新要求。蛋白质组学驱动的分子分型为精准医学奠定基础。同时，脓毒症相关心肌病、脑病等器官特异性标志物研究也在兴起。代表文献:PMID期刊标题41939863FrontImmunol(2026)Sepsisbiomarkers:recentadvancesandfutureperspectives41962401IntJMedInform(2026)Machinelearningforearlydetectionandpredictionofsepsis:explainabilityandclinicaltranslation41898582IntJMolSci(2026)MachineLearningModelsforSepsis:FromEarlyDetectiontoShort-andLong-TermPrognosis41890740FrontImmunol(2026)Sepsis-inducedcardiomyopathy:mechanisms,epidemiology,diagnosis,andmanagement41896381InflammRes(2026)Proteomicprofilingandpathwayanalysesrevealmolecularsignaturesandimmunedysregulationinpediatricsepsis热点三：细胞程序性死亡与NETosis免疫病理热度指标:pyroptosis(4次),extracellulartraps(5次),neutrophils(6次),macrophages(6次),cytokines(10次),inflammation(9次)热点分析:GasderminD介导的**焦亡(Pyroptosis)**是2024-2026年脓毒症领域最受关注的细胞死亡方式。NETosis(中性粒细胞胞外诱捕网形成)与血小板交互作用在免疫血栓形成中的角色被重新评估。USP15-TRIM21-GSDMD等新型调控通路不断被揭示。程序性细胞死亡的谱系框架正在重构——将NETosis纳入更广泛的调节性细胞死亡(RCD)体系。代表文献:PMID期刊标题42094003FrontImmunol(2026)GasderminD-drivenpyroptosisinsepsis:mechanisms,therapeuticstrategies,andclinicalperspectives42141379ScandJImmunol(2026)MolecularMechanismsofNETsandPlateletInteractionsandTheirRegulatoryRoleinSepsis42050159InflammRes(2026)Regulatedcelldeathinsepsis:reframingNETosiswithinthespectrumofpyroptosisandnecroptosis42114328IntImmunopharmacol(2026)USP15regulatesTRIM21/GSDMDpathwaytoaffectLPS-inducedacuteliverinjuryinsepsis42085842IntImmunopharmacol(2026)TargetingiNOSandassociatedproteinsinneutrophils:Anin-silicoandex-vivoapproachforsepsis热点四：肠道微生物组与脓毒症肠-器官轴热度指标:gastrointestinalmicrobiome(4次),microbiology(26次),dysbiosis,lipopolysaccharides(4次)热点分析:肠道菌群失调(Dysbiosis)与脓毒症预后的因果关系被越来越多证据支持。研究重点关注：①脓毒症早期胃肠功能障碍与菌群动态变化的双向关系；②益生菌在新生儿脓毒症/NEC中的干预价值；③肠道屏障破坏导致LPS易位的分子机制。婴幼儿重症肺炎继发脓毒症的肠道微生物组特征也是新热点。代表文献:PMID期刊标题42079748FrontCellInfectMicrobiol(2026)Theinterplaybetweengastrointestinaldysfunctionandgutmicrobiotadynamicsinsepsis42074240IntJMolSci(2026)AReviewofProbioticInterventionsforNecrotizingEnterocolitisandSepsisinPretermInfants42099619FrontImmunol(2026)Gutmicrobiotadysbiosisininfantsandyoungchildrenwithseverepneumoniaandsepsis热点五：多组学与系统生物学整合分析热度指标:genetics(60次),transcriptome(5次),geneexpressionprofiling(6次),computationalbiology(3次),proteininteractionmaps(3次)热点分析:多组学整合(Multi-omics)正成为脓毒症研究的标配方法。生信分析揭示脓毒症与心梗等共病的交叉对话基因网络。TCR组库(TCRrepertoire)分析揭示脓毒症与非感染性炎症的T细胞免疫差异。单细胞组学推动免疫细胞亚群精细分型。表观遗传学(组蛋白修饰、DNA甲基化)在脓毒症免疫麻痹中的角色获得关注。代表文献:PMID期刊标题42148128FrontImmunol(2026)Multi-omicsanalysisidentifiesNFIL3asahypoxia-associatedimmuneregulatorinsepsis-inducedcardiomyopathy41863100AnnMed(2026)Integratedbioinformaticsanalysisrevealscross-talkinghubgenesbetweensepsisandAMI41948606HumMutat(2026)ImmunomodulatoryRolesandClinicalSignificanceofGZMMandDDX24inSepsis:AMulti-omicsStudy41853277FrontImmunol(2026)DistinctlandscapesofT-cellimmunityandTCRrepertoirebetweensepsisandnon-infectiousSIRS热点六：免疫细胞重编程与表型转换热度指标:cellularreprogramming(3次),epigenesis(3次),macrophages,immunology热点分析:巨噬细胞从M1促炎向M2修复的表型转换(Macrophagereprogramming)是2026年的新兴趋势。小胶质细胞重编程在脓毒症相关脑病(SAE)中的研究开辟了新方向。表观遗传重编程(Epigeneticreprogramming)被视为逆转脓毒症免疫抑制的新策略。免疫训练(Trainedimmunity)概念开始渗透脓毒症研究。代表文献:PMID期刊标题41846911FrontImmunol(2026)Macrophagereprogrammingandfunctionalplasticityinsepsis42079669FrontImmunol(2026)Reprogrammingmicrogliainsepsis-associatedencephalopathy:frompathologicalactivationtotherapeuticresolution41869341FrontImmunol(2026)Lactyla